Catalyst Biosciences Inc (NASDAQ:CBIO)
| 0.5502 Delayed Data As of Nov 23 |  0.00 / 0.00%Today’s Change | 0.35 Today|||52-Week Range 2.09 | -39.80% Year-to-Date |
Latest CBIO News | Press Releases
No recent news for Catalyst Biosciences Inc.
Today’s Trading
| Previous close | 0.55 |
| Today’s open | 0.55 |
| Day’s range | 0.55 - 0.55 |
| Volume | 603 |
| Average volume (3 months) | 511,042 |
| Market cap | $17.9M |
Data as of 3:54pm ET, 11/23/2022
Growth & Valuation
| Earnings growth (last year) | +2.13% |
| Earnings growth (this year) | +131.36% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -64.97% |
| P/E ratio | 1.4 |
| Price/Sales | 3.82 |
| Price/Book | 0.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GENEGenetic Technologies... | +0.00 | +0.23% |
| ITRMIterum Therapeutics ... | +0.04 | +2.68% |
| VCNXVaccinex Inc | -0.03 | -5.82% |
| YMTXYumanity Therapeutic... | 0.00 | 0.00% |
Data as of 12:59pm ET, 11/25/2022
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $7.3M |
| Annual profit (last year) | -$87.9M |
| Net profit margin | -1,198.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
